Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.
J Allergy Clin Immunol. 2013 Jan;131(1):110-6.e1. doi: 10.1016/j.jaci.2012.07.047. Epub 2012 Sep 27.
J Allergy Clin Immunol. 2013.
PMID: 23021878
Clinical Trial.
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.
Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F, De Ruyck N, Blomme K, Sousa AR, Marshall RP, Bachert C.
Gevaert P, et al. Among authors: blomme k.
J Allergy Clin Immunol. 2011 Nov;128(5):989-95.e1-8. doi: 10.1016/j.jaci.2011.07.056. Epub 2011 Sep 28.
J Allergy Clin Immunol. 2011.
PMID: 21958585
Free article.
Clinical Trial.
Item in Clipboard
Prevalence of allergic sensitization versus allergic rhinitis symptoms in an unselected population.
Blomme K, Tomassen P, Lapeere H, Huvenne W, Bonny M, Acke F, Bachert C, Gevaert P.
Blomme K, et al.
Int Arch Allergy Immunol. 2013;160(2):200-7. doi: 10.1159/000339853. Epub 2012 Sep 25.
Int Arch Allergy Immunol. 2013.
PMID: 23018768
Item in Clipboard
Cite
Cite